Fronteo And Axcelead Ddp Forge Essential Ai-Enabled Drug Discovery Support Partnership

Fronteo Co Ltd and Axcelead Drug Discovery Partners Co., Ltd. have recently entered into a foundational partnership agreement to enhance AI-driven support for drug discovery. FRONTEO specializes in the "Drug Discovery AI Factory" business, providing services that enhance the efficiency, speed, and success rates of drug discovery using their proprietary AI technology for generating hypotheses in drug research and development. In contrast, Axcelead DDP possesses the vital platform capabilities required for drug discovery and supports drug discovery research for various stakeholders, including pharmaceutical companies, bioventures, academic institutions, and government research bodies. This partnership agreement enables collaboration between FRONTEO's AI-driven hypothesis generation capabilities and Axcelead DDP's drug discovery platform in forming hypotheses through both dry research (computer and AI-based data analysis) and wet research (involving laboratory work with cells and animals). This collaborative approach allows for the efficient testing and validation of these hypotheses using biological experiments.

FRONTEO, expressed, "As we advance our Drug Discovery AI Factory business, we have received numerous requests from our client companies to handle the subsequent wet research required to validate the hypotheses derived from dry research. This partnership with Axcelead DDP will enable us to meet these demands and further contribute to the advancement of our clients' drug discovery research and the enhancement of healthcare quality. We are thrilled to be able to do this."

Axcelead DDP, stated, "We are delighted to strengthen our AI-based drug discovery support services through this partnership with FRONTEO, which excels in data analysis utilizing hypothesis-generating AI. By conducting wet research based on the drug discovery research expertise we have cultivated, we will significantly accelerate our clients' drug discovery efforts. As a platform company, we are committed to facilitating the development of innovative new drugs for our clients."

Optimize Your trial insights with Clival Database.

Are you exhausted from the uncertainty of trial insights pricing? Clival Database ensures the clarity in the midst of the global scenario for clinical trials to you.

Clival Database is one of the best databases that offers an outstanding number of clinical trial data in terms of 50,000+ molecules and from primary regulatory markets as well as new entrants like Indian and Chinese markets.

With Clival, you get accurate positioning of historical sales data, patent database, company profiling, safety & efficacy, and prediction of launch of new innovative molecules helping you to align your research and driving down the cost.

To add value, we further break down our analytics for you so that improving your operational effectiveness; optimizing your clinical trials; and offering you accurate and high-quality data at lowest possible prices becomes possible.

Elevate your trial success rate with the cutting-edge insights from Clival database.

Check it out today and make more informed sourcing decisions! Learn More!